We are the parent entity of a leading Chinese pharmaceutical company specializing in urology products. We are working with our China subsidiary to expand their product offering and product pipeline of pharmaceuticals, diagnostics and medical devices.We are looking to license products with significant potential from innovative companies that want access to the China market.
This will likely be the second largest pharmaceutical in the world. We are especially interested in products that have regulatory approval outside of China or are well advanced in their clinical trials.
We offer ready access to all three segments of the urology market. In addition, we have significant local knowledge necessary for the successful regulatory approval, introduction and market development of new urology products.